Clinical Breast Cancer, Volume 23, Issue 2, February 2023, Pages 211-218
This Study supports SDGs 3, 5 and 10 by highlighting the significant variability in insurance coverage of Prophylactic Mastectomy (PM) between companies which can lead to further inequalities in access to this breast cancer risk reducing procedure. Physicians and patients alike should advocate for fair and equal access to PM for certain clinical indications.
eClinicalMedicine, Volume 54, December 2022
This Article supports SDG 3 by characterizing unmet needs and experiences of caregivers of patients with Erdheim-Chester disease and other histiocytic neoplasms and identifies factors associated with finding benefit and meaning-making in providing care for patients with rare cancers.